Clinical Trials Logo

Painful Diabetic Neuropathy clinical trials

View clinical trials related to Painful Diabetic Neuropathy.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01556152 Withdrawn - Clinical trials for Painful Diabetic Neuropathy

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Start date: n/a
Phase: Phase 2
Study type: Interventional

Diabetic peripheral neuropathy (DPN) represents a diffuse symmetric and length-dependent injury to peripheral nerves that has major implications on quality of life (QOL), morbidity, and costs from a public health perspective. Painful diabetic neuropathy affects 16% of patients with diabetes. Pharmacological agents used in the management of painful DPN mainly include tricyclic antidepressants, selective serotonin and norepinephrine reuptake inhibitors, opioids, and anti epileptic drugs. However, only two drugs (duloxetine and pregabalin) have been formally approved by the EMEA and the US FDA for the treatment of painful DPN. Generally, the available treatment options do not give total relief, are not effective in all patients, and only about one-third of patients may achieve more than 50% pain relief. Hence newer therapies are required for the treatment of DPN. This is randomized, double-blind, placebo-controlled, parallel group study. The study will include patients with type 1 or type 2 diabetes mellitus with history of pain attributed to DPN for least 6 months and no greater than 5 years. Patients will be recruited after providing written informed consent.

NCT ID: NCT00837941 Withdrawn - Clinical trials for Painful Diabetic Neuropathy

A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)

Start date: April 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if analgesic efficacy can be detected with single dose administration in patients with chronic neuropathic pain due to painful diabetic neuropathy.